What can we learn from Wegovy and what can manufacturers do to unlock better health for patients globally?
The recent introduction of Wegovy has garnered attention from clinical and economic stakeholders alike, causing a shift in the treatment paradigm for obesity. What can manufacturers learn from Wegovy to unlock better health for patients globally? We share key learnings in our article.
| Blog | Healthcare & Life Sciences Pharma & Biotechnology Commercial Strategy & Pricing Consulting Customer, Product & Market Strategy